Investor List:

Top Drug Delivery Seed Investors in San Francisco Bay Area (18)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Milad Alucozai, Investor at BoxOne Ventures
Milad Alucozai
BoxOne Ventures·Investor
Sweet spot: $300K
Range: $100K - $1M
Investors in Boston (MA), Investors in Chicago (IL), Investors in Montreal, Investors in Toronto (Ontario), Investors in San Francisco (CA)
Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Hardware (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Analytics (Seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Analytics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in Hardware (Seed), Investors in SaaS (Pre-seed), Investors in AI (Seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Seed), Investors in Health IT (Seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in Analytics (Seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Seed), Investors in SaaS (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in SaaS (Seed), Investors in BioTech (Seed), Investors in Analytics (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Pre-seed), Investors in Health IT (Seed), Investors in AI (Pre-seed), Investors in BioTech (Seed), Investors in Hardware (Seed), Investors in Hardware (Pre-seed), Investors in SaaS (Seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in British Columbia (Other Lists), Investors in AI (Seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in SaaS (Pre-seed), Investors in SaaS (Seed), Investors in Health & Hospital Services (Seed), Investors in Midwest (Other Lists), Investors in Health IT (Seed), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in SaaS (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Omri Amirav Drory, General Partner at NFX
Omri Amirav Drory
NFX·General Partner
Sweet spot: $3.0M
Range: $500K - $5.0M
Investors in SF Bay Area (CA)
Photo of Matt Krisiloff, Investor at SciFounders
Matt Krisiloff
SciFounders·Investor
Sweet spot: $400K
Range: $400K - $400K
Investors in SF Bay Area (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Seed), Investors in BioTech (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series A), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Gita Reinitz, Principal at NFX
Gita Reinitz
NFX·Principal
Sweet spot: $1M
Range: $500K - $5.0M
Investors in Israel, Investors in SF Bay Area (CA)
Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Israel (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Andres Carbonell, Investor at Plug & Play Ventures
Andres Carbonell
Sweet spot: $100
Range: $25 - $500
Investors in Sunnyvale (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Consumer Health (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Data Services (Series A), Investors in Consumer Health (Seed), Investors in Data Services (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Data Services (Series A), Investors in Data Services (Seed), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in Chemicals (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in AgTech (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series A), Investors in BioTech (Series B), Investors in Drug Delivery (Series B), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Washington, D.C. (Other Lists), Investors in Chemicals (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in AgTech (Series A), Investors in Diagnostics (Series B), Investors in Diverse Investors (Other Lists), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Steven Berger, Managing Director at Asahi Kasei Corporate Venture Capital
Steven Berger
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts, Investors in Berkeley (CA)
Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Seed), Investors in AutoTech (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in Drug Delivery (Series B), Investors in AutoTech (Series B), Investors in ConstructionTech (Series B), Investors in Drug Delivery (Pre-seed), Investors in ConstructionTech (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in ConstructionTech (Seed), Investors in AutoTech (Seed), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in AutoTech (Pre-seed), Investors in AutoTech (Series A), Investors in Impact (Series B), Investors in AutoTech (Series B), Investors in Impact (Pre-seed), Investors in EnergyTech (Series B), Investors in Food and Beverage (Pre-seed), Investors in Digital Health (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in ConstructionTech (Series B), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in IoT (Series B), Investors in Food and Beverage (Series A), Investors in AutoTech (Series A), Investors in Impact (Series A), Investors in IoT (Pre-seed), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in ConstructionTech (Series A), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Digital Health (Series B), Investors in Impact (Series B), Investors in Impact (Seed), Investors in AutoTech (Seed), Investors in EnergyTech (Seed), Investors in ConstructionTech (Seed), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in IoT (Series A), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Series B), Investors in IoT (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series A), Investors in IoT (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in IoT (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Digital Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Series A), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Seed), Investors in Digital Health (Series A), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Digital Health (Series B), Investors in EnergyTech (Seed), Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in IoT (Seed), Investors in Digital Health (Series A), Investors in IoT (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Digital Health (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Abraham Chaibi, General Partner at Dexterity Capital
Abraham Chaibi
Dexterity Capital·General Partner
Sweet spot: $100K
Range: $25K - $2.0M
Investors in SF Bay Area (CA)